University of Ottawa

$297,381.00 CAD

≈ 4 Canadians' average pay for a year
Department
National Research Council Canada
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient country
Canada
Fiscal year
2020-2021
Agreement period
February 26, 2021 – February 28, 2022
Reference
nrc-cnrc:172-2020-2021-Q4-967823

Published purpose

There is an urgent need for research focused on slowing and stopping the spread of SARS-CoV-2 in vulnerable populations. Canada’s elderly are particularly vulnerable to SARS-CoV-2 infection and in particular appear to be more susceptible to pulmonary and systemic hyper-inflammation, causing multiorgan failure following infection. Researchers hypothesize that lipids and metabolites act as major regulators of cytokines and inflammation response and thus provide an avenue for response-informed diagnostics and theragnostics. The research outlined in this Project will seek to understand how lipids and metabolites act as major regulators of cytokines and related inflammation response. Researchers aim to establish lipidomic and metabolomics indices of risk that may be used to identify, intervene, and mitigate the lasting negative effects of SARS-CoV-2 infection on the quality of life of survivors. This work aims to contribute to the overarching objectives of enhancing local, national, and international efforts to mitigate the related negative consequences of COVID-19.

Community tags

Tags are applied by readers, not by this site. One tag per person per record.

Good value Local impact Needs context Questionable Success story Wasteful
View official source record Imported July 30, 2026 from open.canada.ca Grants & Contributions